Advertisement
 

Loss narrows at MannKind

Earnings Roundup

May 06, 2008|From Times Wire Services

Biotechnology firm MannKind Corp. said its first-quarter loss narrowed on lower research and development costs.

Valencia-based MannKind lost $71.4 million, or 70 cents a share, compared with a loss of $73.1 million, or $1, a year earlier. Revenue rose to $20,000 from $10,000.

Analysts polled by Thomson Financial expected a loss of 79 cents a share, with no revenue.

Research and development expenses fell 8% to $58.4 million, more than offsetting a 15% rise to $15.7 million in general and administrative expenses.

Shares rose 4 cents to $2.55.

FEATURED

Skechers lawsuit: How to get your piece of the $40-million payout

Hard crash ends Danica Patrick's NASCAR race at Indianapolis

How to find your lost or stolen iPhone 5

MORE:

Top 10 cars: best gas mileage, lowest sticker price

Upsets abound in Farmers Classic quarterfinals as Ram, Berankis advance

Advertisement
Los Angeles Times Articles
Copyright 2013 Los Angeles Times
Terms of Service
|
Privacy Policy
|
Index by Date
|
Index by Keyword